Clinical trial

Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm…

NCT00327730 · Eisai Inc., Industry · Completed

Key facts

NCT number NCT00327730
Title Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain - A Double Blind, Randomised, Placebo Controlled Clinical Trial
Official title Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain
Lead sponsor Eisai Inc., Industry
Collaborators Eisai Co., Ltd. Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Muscle Spasm, Back Pain
Intervention type Drug
Interventions Eperisone
Enrollment 240
Start date Apr 1, 2006
Primary completion Jun 1, 2006
Completion Jun 1, 2006
First posted May 18, 2006
Last update posted Apr 21, 2014
Countries India

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies